GGF2 (Nrg1-β3) treatment enhances NG2+ cell response and improves functional recovery after spinal cord injury
| Autor: | Junfang Wu, Ahdeah Pajoohesh-Ganji, Matthew Whittaker, April Sharp, Ransom Wyse, Hyun Joon Lee, Jean R. Wrathall, Laila J. Zai |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
Neuregulin-1 Basic fibroblast growth factor Mice Transgenic Nerve Fibers Myelinated Rats Sprague-Dawley Mice Cellular and Molecular Neuroscience chemistry.chemical_compound medicine Animals Remyelination Growth Substances Spinal cord injury Spinal Cord Injuries Gliogenesis business.industry Stem Cells Cell Differentiation Recovery of Function medicine.disease Spinal cord Recombinant Proteins Oligodendrocyte Nerve Regeneration Rats Up-Regulation Cell biology Disease Models Animal Oligodendroglia medicine.anatomical_structure Neurology chemistry Immunology Neuregulin Female Schwann Cells Stem cell business |
| Zdroj: | Glia. 60:281-294 |
| ISSN: | 0894-1491 |
| DOI: | 10.1002/glia.21262 |
| Popis: | The adult spinal cord contains a pool of endogenous glial precursor cells, which spontaneously respond to spinal cord injury (SCI) with increased proliferation. These include oligodendrocyte precursor cells that express the NG2 proteoglycan and can differentiate into mature oligodendrocytes. Thus, a potential approach for SCI treatment is to enhance the proliferation and differentiation of these cells to yield more functional mature glia and improve remyelination of surviving axons. We previously reported that soluble glial growth factor 2 (GGF2)- and basic fibroblast growth factor 2 (FGF2)-stimulated growth of NG2+ cells purified from injured spinal cord in primary culture. This study examines the effects of systemic administration of GGF2 and/or FGF2 after standardized contusive SCI in vivo in both rat and mouse models. In Sprague-Dawley rats, 1 week of GGF2 administration, beginning 24 h after injury, enhanced NG2+ cell proliferation, oligodendrogenesis, chronic white matter at the injury epicenter, and recovery of hind limb function. In 2′,3′-cyclic-nucleotide 3′-phosphodiesterase-enhanced green fluorescent protein mice, GGF2 treatment resulted in increased oligodendrogenesis and improved functional recovery, as well as elevated expression of the stem cell transcription factor Sox2 by oligodendrocyte lineage cells. Although oligodendrocyte number was increased chronically after SCI in GGF2-treated mice, no evidence of increased white matter was detected. However, GGF2 treatment significantly increased levels of P0 protein-containing peripheral myelin, produced by Schwann cells that infiltrate the injured spinal cord. Our results suggest that GGF2 may have therapeutic potential for SCI by enhancing endogenous recovery processes in a clinically relevant time frame. © 2011 Wiley Periodicals, Inc. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text